Skip to Content

News Releases


Hitachi Announces Supria® True64 CT Compact Design Receives FDA Clearance

Twinsburg, OH September 14, 2017 - Hitachi Healthcare Americas, Inc., a leading provider of advanced imaging solutions announced it has attained FDA 510(k) clearance to market its Supria True64 Computed Tomography System, the premier model within Hitachi’s Supria compact CT family.

The Supria True64 is a remarkably compact, economical and clinically versatile CT with 64 discrete detector and electronics processing channels to provide rapid thin 64-slice imaging across its full 40mm detector coverage. Supria True64 also emphasizes enhanced workflow capabilities, is XR-29 Smart Dose compliant and adds a new environmental efficiency feature “Eco-Mode” that reduces power consumption by up to 55% during idle periods.

“The Supria True64 in a compact footprint combines enhanced patient access with its enlarged 75cm aperture and standard 500 lbs. weight capacity table and premium image quality provided by True 64 slice scanning. Some compact CT products actually acquire only 32 slices and use software upscaling to produce 64-slice results. Supria True64 does not make the compromises inherent to slice upscaling methods”, said Mark Silverman, Director - CT Marketing.

“The SupriaTrue64 continues Hitachi’s commitment to providing imaging solutions with enhanced speed, comfort and quality. Being mindful of the intense economic and workflow pressures being experienced by CT providers, Hitachi once again is demonstrating our ability and commitment to provide a higher level of CT capabilities at an economic price point”, said Sheldon Schaffer, VP & General Manager MR/CT.


Hitachi Healthcare Americas, located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Healthcare Business Unit, offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike and play an important role in the diagnosis and treatment of disease while driving social innovation into healthcare. Visit


Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges. The company’s consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled 9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global leader in the Social Innovation Business, and it has approximately 304,000 employees worldwide. Through collaborative creation, Hitachi is providing solutions to customers in a broad range of sectors, including Power / Energy, Industry / Distribution / Water, Urban Development, and Finance / Government & Public / Healthcare. For more information on Hitachi, please visit the company’s website at

Press Contact

David Wilson

Hitachi Healthcare Americas

+1 330 425-1131 x3385

back to top